Skip to main content

Exactech Agrees On Summary Judgment For AcuMatch Hip Implant

Exactech Agrees On Summary Judgment For AcuMatch Hip Implant

Exactech Agrees On Summary Judgment For AcuMatch Hip Implant

Introduction

In a motion filed on August 14 in the Eastern District of Tennessee, Exactech Inc. agreed on a summary judgment in a plaintiff's case involving allegations regarding the company's AcuMatch hip implant. The move was taken considering the company's declaration that there was no written warranty that the device had a shelf life of more than 15 years; hence, the case could be barred under Texas law. The manufacturer challenges the evidence and testimony, stating that neither the plaintiff nor the performing surgeon counted on the written warranty details for the hip implant.

Similar allegations are piling up in the federal courts across the U.S. against other hip implant manufacturers including Zimmer, Biomet, and Stryker. Zimmer has settled many of the lawsuits between 2016 and 2017, but as of August 2018, about 131 cases linked to complications due to Zimmer Durom Hip Cup Implant, are still pending in the Multidistrict Litigation ( MDL No. 2158 (In Re: Zimmer Durom Hip Cup Products Liability Litigation), which is overlooked by Judge Susan D. Wigenton in the U.S. District for New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

FDA Launches New Panel to Review Talc Safety

Categories: Talcum

A panel of independent scientific experts convened this week at the request of the U.S. Food and Drug Administration (FDA) to evaluate the potential health risks associated with talc…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!